Coronavirus vaccine development: from SARS and MERS to COVID-19
SARS-CoV-2 is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19). It has been the most challenging pandemic in this century...
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020
Pfizer-BioNTech COVID-19 vaccine has reported 4,393 (0.2%) adverse events in the Cases of anaphylaxis were determined to be rare but still under inve...
COVID-19 vaccine research and development: ethical issues
The achievements of vaccine research and development bring a hope to our societies that we may cope with the COVID-19 pandemic. There are two aspects...
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples
Vaccines have been developed in unprecedented time and quantifying levels of hesitancy towards vaccination among the general population is of importan...
Global Recommendations on COVID-19 Vaccines and Soft Tissue Filler Reactions: A Survey-Based Investigation in Cooperation With the International Society for Dermatologic and Aesthetic Surgery (ISDS)
Concerns have been expressed about the association of soft tissue filler injections and the COVID-19 vaccines. The International Society for Dermatolo...
Vaccine Hesitancy and Demand for Immunization in Eastern Europe and Central Asia: Implications for the Region and Beyond
Vaccine hesitancy has become a growing concern globally. It calls into question the safety and efficacy of vaccines. It threatens the progress made in...
COVID-19 vaccines: Global challenges and prospects forum recommendations
The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was held...
COVID-19 vaccines: Global challenges and prospects forum recommendations
The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was held...